Delivery Order SPE2DB22D2206-SPE2DB25FJV68
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $36,457.87 to AmerisourceBergen Drug Corp for YERVOY (ipilimumab) 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract was awarded on August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $114,789.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of YERVOY 200 mg/40 mL vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 28, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $25,022.41 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Yervoy 200 mg/40 mL vials. The contract represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide YERVOY 50 MG/10 ML VIAL 10ML. The $11,435.46 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $11,435.46 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials. This delivery order, issued on September 4, 2025, represents a competitive, non-set-aside award with firm fixed pricing and an ultimate completion date of September 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Yervoy is an immunotherapy medication used in cancer treatment, reflecting the Defense...
- This is a $11,435.46 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a $11,435.46 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML pharmaceutical products, with a period of performance through July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563875830 YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The delivery order has a potential value of $18,459.12 and a completion date of March 27, 2024. This order is placed under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and...
- This is a $45,915.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 mg/40 ml vials of the medication YERVOY through July 30, 2025. It is not a set-aside contract, indicating open competition. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,142,126 units of the medication YERVOY 50 MG/10 ML VIAL 10ML. The contract has a ceiling value of $22,870.92 and a period of performance through May 27, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV68Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of YERVOY (ipilimumab) 50 mg/10 mL vials, with a contract ceiling value of $22,870.92. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set to be completed by September 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. YERVOY is an immunotherapy medication used to treat certain cancers and is a critical pharmaceutical for military and veteran healthcare systems. AmerisourceBergen's role as a pharmaceutical prime vendor enables the company to fulfill a broad range of federal medical supply needs across multiple therapeutic domains. The DLA's Troop Support Medical supply chain relies on established contractors like AmerisourceBergen to efficiently distribute specialty medications and medical commodities to support military healthcare programs globally, including services to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 9/9/25 |